RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Ferrini, Monica
PropertyValue
keywords Fibrosis
overview Dr. Monica G. Ferrini holds an MS in Biochemistry and a Ph.D. in Physiology from the University of Buenos Aires, Argentina. As a pre-doctoral and postdoctoral fellow, she worked on the interaction between estrogen and glucocorticoid receptors in the brain, as it relates to sexual dimorphism, aging, and its stress response. During this time, she focused on the role of the glucocorticoid receptor in aging within the central nervous system and found that estradiol has a potent effect on the aged male brain in response to stress through the regulation of the glucocorticoid receptors. This was the first indication that the decreased levels of reproductive hormones modulated neuronal cytotoxicity and the impaired response to stress that occurs with aging. In February 1999, Dr. Ferrini joined the Division of Urology at Harbor-UCLA Medical Center and LaBiomed as a visiting scholar to work on the role of inducible nitric oxide synthase (iNOS) in the central nervous system and the lower urinary tract in aging. She found that iNOS is a key factor in two opposing pathological processes, namely neurotoxicity in critical related regions of the hypothalamus during senescence, and as a defense mechanism against aging or injury-associated fibrosis in the lower urinary tract. Due to these findings, she directed her research on studying the role of iNOS on fibrosis and oxidative stress in the lower urinary tract in different conditions such as Peyronie’s disease, diabetes, and aging. By counteracting fibrosis and oxidative stress, the nitric oxide derived by iNOS would improve smooth muscle compliance thus enhancing erectile function. In January of 2008, Dr. Ferrini joined Charles R. Drew University (CDU) as an Assistant Professor. She focused her research on the effect of PDE5 inhibitors in counteracting corporal fibrosis associated with neuropraxia or nerve damage as a consequence of radical prostatectomy for prostate cancer. Currently, she is an Associate Professor and Chair of the Department of Health and Life Sciences at CDU. She is the director of the BS in Biomedical Sciences and the MS in Biomedical Sciences at CDU. Recently, her laboratory is geared towards performing translational research where they examine the efficacy of nutraceuticals that modulates the production of nitric oxide in the prevention of osteoporosis. With more than 90 papers in peer review journals in the field of neurobiology and urology, Dr. Monica Ferrini gives her expertise to the scientific community as she has been passionate about providing effective teaching, mentoring, and research training to a large number of undergraduate and graduate students.
One or more keywords matched the following items that are connected to Ferrini, Monica
Item TypeName
Grant Nitric Oxide/cGMP Modulation of Corporal Fibrosis Caused by Neuropraxia
Academic Article Pioglitazone prevents corporal veno-occlusive dysfunction in a rat model of type 2 diabetes mellitus.
Academic Article Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: implications for vaginal fibrosis.
Academic Article Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Academic Article Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat.
Academic Article Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction.
Academic Article The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes.
Academic Article Profibrotic role of myostatin in Peyronie's disease.
Academic Article Ageing-related corpora veno-occlusive dysfunction in the rat is ameliorated by pioglitazone.
Academic Article Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection.
Academic Article Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.
Academic Article Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat.
Academic Article Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-?1 therapies in inducible nitric oxide synthase-deficient mice.
Academic Article Treatment with a combination of ginger, L-citrulline, muira puama and Paullinia cupana can reverse the progression of corporal smooth muscle loss, fibrosis and veno-occlusive dysfunction in the aging rat.
Academic Article Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media.
Academic Article L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Academic Article Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat.
Academic Article The Combination of High-Fat Diet and Oral Marijuana Promotes the Development of Fibrosis in the Mouse Corpora Cavernosa.
Search Criteria
  • Fibrosis
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support